Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey

BACKGROUND: Durvalumab as maintenance treatment after platinum-based concurrent chemoradiotherapy (cCRT) has become the standard of care in inoperable stage III non-small cell lung cancer (NSCLC). In this nationwide survey, we solicited members of the German Radiation Oncology Society to review the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transl Lung Cancer Res
Hoofdauteurs: Käsmann, Lukas, Eze, Chukwuka, Taugner, Julian, Roengvoraphoj, Olarn, Belka, Claus, Manapov, Farkhad
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AME Publishing Company 2020
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225149/
https://ncbi.nlm.nih.gov/pubmed/32420068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.03.25
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items